Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial (Q33912512)

30 July 2017

Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial (English)

1 reference

30 July 2017

1 reference

Deconinck E

1

1 reference

30 July 2017

Lamy T

2

1 reference

30 July 2017

Foussard C

3

1 reference

30 July 2017

Gaillard F

4

1 reference

30 July 2017

Delwail V

5

1 reference

30 July 2017

Colombat P

6

1 reference

30 July 2017

Casassus P

7

1 reference

30 July 2017

Lemevel A

8

1 reference

30 July 2017

Brion A

9

1 reference

30 July 2017

Milpied N

10

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

British Journal of Haematology

30 July 2017

1 reference

30 July 2017

109

1 reference

30 July 2017

4

1 reference

30 July 2017

736-742

1 reference

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02098.X

10.1046/J.1365-2141.2000.02098.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference